LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹2.14 Cr | ₹-17 Cr | ₹9.21 Cr | ₹41 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of LASA SUPERGENERICS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹2.14 Cr |
Mar2023 | ₹-17 Cr |
Mar2022 | ₹9.21 Cr |
Mar2021 | ₹41 Cr |
Mar2020 | ₹14 Cr |
How is Cash Flow from Operating Activities of LASA SUPERGENERICS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹2.14 Cr | Positive | |
Mar2023 | ₹-17 Cr | Negative | |
Mar2022 | ₹9.21 Cr | -77.70 | |
Mar2021 | ₹41 Cr | 203.24 | |
Mar2020 | ₹14 Cr | - |
Compare Cash Flow from Operating Activities of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹70.3 Cr | -6.5% | -15.8% | -38.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -6.5% |
-15.8% |
-38.2% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses